Abbonarsi

Interventions to reduce infections caused by multidrug resistant Enterobacteriaceae (MDR-E): A systematic review and meta-analysis - 24/07/21

Doi : 10.1016/j.jinf.2021.05.005 
Heyam Atamna-Mawassi a, Maayan Huberman-Samuel a, Shimrit hershcovitz a, Nitzan Karny-Epstein b, Axel Kola c, Luis Eduardo López Cortés d, Leonard Leibovici a, e, Dafna Yahav e, f,
a Medicine E, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel 
b Medicine B, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel 
c Institute for Hygiene and Environmental Medicine, National Reference Centre for the Surveillance of Nosocomial Infections, Charité-University Hospital, Berlin, Germany 
d Department of Infectious Diseases, Hospital Universitario Virgen Macarena, Instituto de Biomedicina de Sevilla (IBiS), Sevilla, Spain 
e Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel 
f Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel 

Corresponding author at: Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, 39 Jabotinsky Road, Petah-Tikva 49100, Israel.Infectious Diseases Unit, Rabin Medical CenterBeilinson Hospital39 Jabotinsky RoadPetah-Tikva49100Israel

Highlights

A systematic review and meta-analysis including 63 studies.
Antimicrobial stewardship was found to reduce colonization with MDR-E, but not infection.
Decolonization did not result in reduction of MDR-E infection or colonization.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Objectives

We aimed to evaluate different interventions to reduce multidrug-resistant Enterobacteriaceae (MDR-E) infection/colonization.

Methods

A systematic review and meta-analysis evaluating interventions for prevention of MDR-E infection/colonization among hospitalized adult patients. The co-primary outcomes were mortality and MDR-E infections. PubMed, Cochrane library, and LILACS databases were searched up till December 2019, as well as grey literature sources. We included randomized controlled trials and observational studies. Infection/colonization/acquisition outcomes were reported per patient-days as pooled incidence ratios (IRs) with 95% confidence intervals (CIs). Interrupted time series (ITS) analysis studies were reported separately.

Results

Sixty-three studies were included, 16 RCTs, 33 observational studies, and 14 ITS. For the intervention of antimicrobial stewardship program (ASP), 23 studies were included. No differences in mortality or MDR-E infections were observed with ASP, however, MDR-E colonization was significantly reduced (IR 0.69, 95% CI 0.57–0.82). Seventeen studies examined decolonization without significant difference in outcomes. Other interventions were scarcely represented. Among 14 ITS publications, most evaluating ASP, 11 showed benefit of the intervention.

Conclusions

ASP is an effective measure in preventing MDR-E colonization. Decolonization did not show significant benefit in reducing infection or colonization. Studies are needed to evaluate the cost effectiveness of ASP and assess bundles of interventions.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Infection prevention and control, Multidrug resistant Enterobacteriaceae, MDR-E, Systematic review and meta-analysis


Mappa


© 2021  The British Infection Association. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 83 - N° 2

P. 156-166 - agosto 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Distinguishing septic shock from non-septic shock in postsurgical patients using gene expression
  • Pedro Martínez-Paz, Marta Aragón-Camino, Esther Gómez-Sánchez, Mario Lorenzo-López, Estefanía Gómez-Pesquera, Alejandra Fadrique-Fuentes, Pilar Liu, Álvaro Tamayo-Velasco, Christian Ortega-Loubon, Marta Martín-Fernández, Hugo Gonzalo-Benito, Emilio García-Morán, María Heredia-Rodríguez, Eduardo Tamayo
| Articolo seguente Articolo seguente
  • Development and evaluation of a nanopore 16S rRNA gene sequencing service for same day targeted treatment of bacterial respiratory infection in the intensive care unit
  • Rossella Baldan, Penelope R. Cliff, Sarah Burns, Adela Medina, Graeme C. Smith, Rahul Batra, Alberto Cerda, Rebekah Wilson, Tammy Merrill, Shona J. Lewis, Amita Patel, Dakshika Jeyaratnam, Duncan L. Wyncoll, Nicholas Barrett, Meera A. Chand, Jonathan D. Edgeworth

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.